Melatonin: a potential therapeutic approach for the management of primary Sjögren’s syndrome

Gupta S, Ferrada MA, Hasni SA. Pulmonary manifestations of primary Sjögren’s syndrome: underlying immunological mechanisms, clinical presentation, and management. Front Immunol. 2019;10:1327. https://doi.org/10.3389/fimmu.2019.01327.

Article  CAS  Google Scholar 

Odani T, Chiorini JA. Targeting primary Sjögren’s syndrome. Mod Rheumatol. 2019;29(1):70–86. https://doi.org/10.1080/14397595.2018.1546268.

Article  Google Scholar 

Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med. 2005;165(20):2337–44. https://doi.org/10.1001/archinte.165.20.2337.

Article  Google Scholar 

Mariette X, Criswell LA. Primary Sjögren’s syndrome. N Engl J Med. 2018;378(10):931–9. https://doi.org/10.1056/NEJMcp1702514.

Article  Google Scholar 

Garcia-Carrasco M, Fuentes-Alexandro S, Escarcega RO, Salgado G, Riebeling C, Cervera R. Pathophysiology of Sjögren’s syndrome. Arch Med Res. 2006;37(8):921–32. https://doi.org/10.1016/j.arcmed.2006.08.002.

Article  CAS  Google Scholar 

Delaleu N, Jonsson MV, Appel S, Jonsson R. New concepts in the pathogenesis of Sjögren’s syndrome. Rheum Dis Clin North Am. 2008;34(4):833–45. https://doi.org/10.1016/j.rdc.2008.08.004.

Article  Google Scholar 

Moutsopoulos HM. Sjögren’s syndrome: a forty-year scientific journey. J Autoimmun. 2014;51:1–9. https://doi.org/10.1016/j.jaut.2014.01.001.

Article  CAS  Google Scholar 

Parisis D, Chivasso C, Perret J, Soyfoo MS, Delporte C. Current state of knowledge on primary Sjögren’s syndrome, an autoimmune exocrinopathy. J Clin Med. 2020;9(7):2299. https://doi.org/10.3390/jcm9072299.

Article  CAS  Google Scholar 

Villalon L, Mamani M, Romanini FE, Catalan PA, Berra A. Primary Sjögren’s syndrome: expression of NF-kappaB in minor salivary glands. Reumatol Clin. 2010;6(6):292–5. https://doi.org/10.1016/j.reuma.2009.10.009.

Article  Google Scholar 

Wakamatsu TH, Dogru M, Matsumoto Y, Kojima T, Kaido M, Ibrahim OM, et al. Evaluation of lipid oxidative stress status in Sjögren syndrome patients. Invest Ophthalmol Vis Sci. 2013;54(1):201–10. https://doi.org/10.1167/iovs.12-10325.

Article  CAS  Google Scholar 

Byun YS, Lee HJ, Shin S, Chung SH. Elevation of autophagy markers in Sjögren syndrome dry eye. Sci Rep. 2017;7(1):17280. https://doi.org/10.1038/s41598-017-17128-0.

Article  CAS  Google Scholar 

Li B, Wang F, Schall N, Muller S. Rescue of autophagy and lysosome defects in salivary glands of MRL/lpr mice by a therapeutic phosphopeptide. J Autoimmun. 2018;90:132–45. https://doi.org/10.1016/j.jaut.2018.02.005.

Article  CAS  Google Scholar 

Nakamura H, Horai Y, Shimizu T, Kawakami A. Modulation of apoptosis by cytotoxic mediators and cell-survival molecules in Sjögren’s syndrome. Int J Mol Sci. 2018;19(8):2369. https://doi.org/10.3390/ijms19082369.

Article  CAS  Google Scholar 

Kapsogeorgou EK, Abu-Helu RF, Moutsopoulos HM, Manoussakis MN. Salivary gland epithelial cell exosomes: a source of autoantigenic ribonucleoproteins. Arthritis Rheum. 2005;52(5):1517–21. https://doi.org/10.1002/art.21005.

Article  CAS  Google Scholar 

Cortes-Troncoso J, Jang SI, Perez P, Hidalgo J, Ikeuchi T, Greenwell-Wild T, et al. T cell exosome-derived miR-142-3p impairs glandular cell function in Sjögren’s syndrome. JCI. JCI Insight. 2020;5(9):e133497. https://doi.org/10.1172/jci.insight.133497.

Article  Google Scholar 

Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, Dörner T. The diagnosis and treatment of Sjögren’s syndrome. Dtsch Arztebl Int. 2017;114(20):354–61. https://doi.org/10.3238/arztebl.2017.0354.

Article  Google Scholar 

Both T, Dalm VA, van Hagen PM, van Daele PL. Reviewing primary Sjögren’s syndrome: beyond the dryness - from pathophysiology to diagnosis and treatment. Int J Med Sci. 2017;14(3):191–200. https://doi.org/10.7150/ijms.17718.

Article  CAS  Google Scholar 

Puéchal X. Granulomatosis with polyangiitis (Wegener’s). Joint Bone Spine. 2020;87(6):572–8. https://doi.org/10.1016/j.jbspin.2020.06.005.

Article  CAS  Google Scholar 

Devauchelle-Pensec V, Mariette X, Jousse-Joulin S, Berthelot JM, Perdriger A, Puechal X, et al. Treatment of primary Sjögren syndrome with rituximab: a randomized trial. Ann Intern Med. 2014;160(4):233–42. https://doi.org/10.7326/M13-1085.

Article  Google Scholar 

Mariette X, Seror R, Quartuccio L, Baron G, Salvin S, Fabris M, et al. Efficacy and safety of belimumab in primary Sjögren’s syndrome: results of the BELISS open-label phase II study. Ann Rheum Dis. 2015;74(3):526–31. https://doi.org/10.1136/annrheumdis-2013-203991.

Article  CAS  Google Scholar 

Meiners PM, Vissink A, Kroese FG, Spijkervet FK, Smitt-Kamminga NS, Abdulahad WH, et al. Abatacept treatment reduces disease activity in early primary Sjögren’s syndrome (open-label proof of concept ASAP study). Ann Rheum Dis. 2014;73(7):1393–6. https://doi.org/10.1136/annrheumdis-2013-204653.

Article  CAS  Google Scholar 

Fiore A, Murray PJ. Tryptophan and indole metabolism in immune regulation. Curr Opin Immunol. 2021;70:7–14. https://doi.org/10.1016/j.coi.2020.12.001.

Article  CAS  Google Scholar 

Claustrat B, Leston J. Melatonin: physiological effects in humans. Neurochirurgie. 2015;61(2-3):77–84. https://doi.org/10.1016/j.neuchi.2015.03.002.

Article  CAS  Google Scholar 

Reiter RJ, Rosales-Corral SA, Liu XY, Acuna-Castroviejo D, Escames G, Tan DX. Melatonin in the oral cavity: physiological and pathological implications. J Periodontal Res. 2015;50(1):9–17. https://doi.org/10.1111/jre.12176.

Article  CAS  Google Scholar 

Carrascal L, Nunez-Abades P, Ayala A, Cano M. Role of melatonin in the inflammatory process and its therapeutic potential. Curr Pharm Des. 2018;24(14):1563–88. https://doi.org/10.2174/1381612824666180426112832.

Article  CAS  Google Scholar 

Reiter RJ, Tan DX, Galano A. Melatonin: exceeding expectations. Physiology (Bethesda). 2014;29(5):325–33. https://doi.org/10.1152/physiol.00011.2014.

Article  CAS  Google Scholar 

Radogna F, Diederich M, Ghibelli L. Melatonin: a pleiotropic molecule regulating inflammation. Biochem Pharmacol. 2010;80(12):1844–52. https://doi.org/10.1016/j.bcp.2010.07.041.

Article  CAS  Google Scholar 

Cipolla-Neto J, Amaral F. Melatonin as a hormone: new physiological and clinical insights. Endocr Rev. 2018;39(6):990–1028. https://doi.org/10.1210/er.2018-00084.

Article  Google Scholar 

Zhao CN, Wang P, Mao YM, Dan YL, Wu Q, Li XM, et al. Potential role of melatonin in autoimmune diseases. Cytokine Growth Factor Rev. 2019;48:1–10. https://doi.org/10.1016/j.cytogfr.2019.07.002.

Article  CAS  Google Scholar 

Miller E, Walczak A, Majsterek I, Kedziora J. Melatonin reduces oxidative stress in the erythrocytes of multiple sclerosis patients with secondary progressive clinical course. J Neuroimmunol. 2013;257(1-2):97–101. https://doi.org/10.1016/j.jneuroim.2013.02.012.

Article  CAS  Google Scholar 

Lopez-Gonzalez A, Alvarez-Sanchez N, Lardone PJ, Cruz-Chamorro I, Martinez-Lopez A, Guerrero JM, et al. Melatonin treatment improves primary progressive multiple sclerosis: a case report. J Pineal Res. 2015;58(2):173–7. https://doi.org/10.1111/jpi.12203.

Article  CAS  Google Scholar 

Cavallo A, Daniels SR, Dolan LM, Bean JA, Khoury JC. Blood pressure-lowering effect of melatonin in type 1 diabetes. J Pineal Res. 2004;36(4):262–6. https://doi.org/10.1111/j.1600-079X.2004.00126.x.

Article  CAS  Google Scholar 

Rasheed AB, Daoud MS, Gorial FI. Diagnostic utility of serum melatonin levels in systemic lupus erythematosus: a case-control study. Reumatismo. 2017;69(4):170–4. https://doi.org/10.4081/reumatismo.2017.998.

Article  CAS  Google Scholar 

Robeva R, Tanev D, Kirilov G, Stoycheva M, Tomova A, Kumanov P, et al. Decreased daily melatonin levels in women with systemic lupus erythematosus - a short report. Balkan Med J. 2013;30(3):273–6. https://doi.org/10.5152/balkanmedj.2013.8064.

Article  CAS  Google Scholar 

Medrano-Campillo P, Sarmiento-Soto H, Alvarez-Sanchez N, Alvarez-Rios AI, Guerrero JM, Rodriguez-Prieto I, et al. Evaluation of the immunomodulatory effect of melatonin on the T-cell response in peripheral blood from systemic lupus erythematosus patients. J Pineal Res. 2015;58(2):219–26. https://doi.org/10.1111/jpi.12208.

Article  CAS  Google Scholar 

Chojnacki C, Wisniewska-Jarosinska M, Walecka-Kapica E, Klupinska G, Jaworek J, Chojnacki J. Evaluation of melatonin effectiveness in the adjuvant treatment of ulcerative colitis. J Physiol Pharmacol. 2011;62(3):327–34.

CAS  Google Scholar 

Keskin G, Keskin D, Inal A, Ilikci R. Serum melatonin levels in Sjögren patients (HUM7P. 310). J Immunol. 2014;192(1_Supplement):184.19.

Liu Y, Chen XQ, Wang F, Cheng B, Zhou G. Melatonin relieves Th17/CD4(-)CD8(-) T cells inflammatory responses via nuclear-receptor dependent manner in peripheral blood of primary Sjögren’s syndrome. Int Immunopharmacol. 2022;109:108778. https://doi.org/10.1016/j.intimp.2022.108778.

Article  CAS  Google Scholar 

Liu Y, Weng X, Wei M, Yu S, Ding Y, Cheng B. Melatonin regulates the immune response and improves Sjögren’s syndrome-like symptoms in NOD/Ltj Mice. Biochem Pharmacol. 2022;201:115073. https://doi.org/10.1016/j.bcp.2022.115073.

Article  CAS  Google Scholar 

Voulgarelis M, Tzioufas AG. Pathogenetic mechanisms in the initiation and perpetuation of Sjögren’s syndrome. Nat Rev Rheumatol. 2010;6(9):529–37. https://doi.org/10.1038/nrrheum.2010.118.

Article  CAS  Google Scholar 

Verstappen GM, Kroese F, Bootsma H. T cells in primary Sjögren’s syndrome: targets for early intervention. Rheumatology (Oxford). 2019;60(7):3088–98. https://doi.org/10.1093/rheumatology/kez004.

Article  CAS  Google Scholar 

Boumba D, Skopouli FN, Moutsopoulos HM. Cytokine mRNA expression in the labial salivary gland tissues from patients with primary Sjögren’s syndrome. Br J Rheumatol. 1995;34(4):326–33. https://doi.org/10.1093/rheumatology/34.4.326.

Article  CAS  Google Scholar 

Verstappen GM, Corneth O, Bootsma H, Kroese F. Th17 cells in primary Sjögren’s syndrome: pathogenicity and plasticity. J Autoimmun. 2018;87:16–25. https://doi.org/10.1016/j.jaut.2017.11.003.

Article  CAS 

留言 (0)

沒有登入
gif